NVIDIA Partners with Health Tech Companies, Mayo Clinic Innovates & much more - Life AI Weekly #1

Hi there,

In this edition of the Silicon Brief, we're diving into the latest developments in AI chips and data centers. Nvidia has been making waves by partnering with various healthcare firms to push forward AI advancements, showcasing the growing intersection between AI technology and healthcare. Meanwhile, SandboxAQ and Google Cloud are collaborating on innovative AI solutions, highlighting the tech industry's continuous efforts to enhance data processing capabilities.

Additionally, AWS has teamed up with General Catalyst to focus on healthcare AI, further emphasizing the sector's potential for transformative change. These partnerships and collaborations are setting the stage for significant advancements in AI infrastructure, promising to reshape how data centers operate and manage complex AI workloads.

Digital health venture funding reached $10.1 billion in 2024, marking a decrease from the previous year, with a focus on early-stage investments and notable trends in mental health and obesity care. Nvidia Corp. has announced partnerships with healthcare technology firms to apply AI in drug discovery and genetic engineering, revealed at the J.P. Morgan Health Care Conference. Every Cure has expanded its partnership with Google Cloud to leverage AI technologies for drug repurposing, aiming to improve treatment discovery and validation.

Isambard-AI supercomputer at the University of Bristol will use AI to develop treatments for Alzheimer's, heart disease, and cancer. Kognitic's AI model enhances clinical trial predictions, reducing errors from 508 to 179 days. Enveda raises $130 million to boost its AI-driven drug discovery platform. Sen-Jam Pharmaceutical launches AI for molecule repurposing to cut development timelines. A28 Therapeutics and GATC Health complete AI analysis of AT-101 cancer drug. InveniAI LLC launches AlphaMeld Corporation for AI drug discovery. Servier and Google Cloud extend AI partnership for pharmaceutical R&D.

Aignostics and Mayo Clinic have developed a new pathology model using 1.2 million slide images to enhance clinical applications. NHS Shared Business Services launches a £150m AI initiative for medical imaging to improve NHS diagnostics. PhaseV and University Health Network collaborate on lupus research using machine learning to aid drug development.

Collate has raised $30 million to automate biotech paperwork using AI, with Redpoint leading the funding round. Illumina and NVIDIA have partnered to enhance genomic sequencing and AI capabilities. Cmbio® acquired Eagle Genomics' e[datascientist]™ platform to boost its bioinformatics and AI/ML capabilities.

SuperDial has acquired MajorBoost to enhance AI-powered phone automation in healthcare. Century Health partners with Nira Medical for AI-curated EHR data from multiple sclerosis patients. Lupa secures $4 million to advance its AI veterinary platform amid a UK vet shortage.